For those considering Wegovy as part of their weight loss strategy, we encourage you to take our free assessment quiz to determine your eligibility for personalized treatment plans
Here are some things to think about
Given their glucose-lowering effects, GLP-1s have become standard of care for type 2 diabetes, supplanting other medication classes such as sulfonylureas.2 In 2023, GLP-1s represented 63% of diabetes spend, up from 38% in 2020.2 While diabetes GLP-1s will continue to account for a greater portion of spend compared to obesity, costs related to GLP-1s prescribed for obesity are expected to grow at a faster rate over the next 3 years
This shift heightens companies' susceptibility to therapeutic-area-specific shocks
En un estudio, las personas que dejaron de tomar las medicinas de a poco en el transcurso de nueve semanas pudieron seguir bajando de peso durante el perodo de reduccin gradual
They can assess whether your symptoms are related to the medication or indicative of an underlying condition that needs attention